{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:42:59Z","timestamp":1750963379786},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:00:00Z","timestamp":1160006400000},"content-version":"vor","delay-in-days":7704,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[1985,9]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> In this study we examined the interaction of opiates with K binding sites in the bovine adrenal medulla. [<jats:sup>3<\/jats:sup>H]Ethylketocyclazocine (EKC), [<jats:sup>3<\/jats:sup>H]etorphine, and [<jats:sup>3<\/jats:sup>H]bremazocine stereoselective bindings were used to assay these interactions. The K sites were found to be heterogeneous: [<jats:sup>3<\/jats:sup>H]bremazocine identified with high affinity all subtypes of these sites. [<jats:sup>3<\/jats:sup>H]EKC, in the presence of saturating concentrations of [D\u2010Ala<jats:sup>2<\/jats:sup>, D\u2010Leut]\u2010enkephalin (DADLE) (5\u03bc<jats:italic>M<\/jats:italic>), was used to identify K<jats:sup>1<\/jats:sup> sites, on which dynorphin A (1\u201313) bound with high affinity. Either [<jats:sup>3<\/jats:sup>H]EKC or [<jats:sup>3<\/jats:sup>H]etorphine in the presence of 5\u03bc<jats:italic>M<\/jats:italic> DADLE identified the K<jats:sup>2<\/jats:sup> subtype. This subtype was found to interact with \u03b2\u2010endorphin and especially with the octapeptide Met<jats:sup>5<\/jats:sup>\u2010enkephalyl\u2010Arg<jats:sup>6<\/jats:sup>\u2010Gly<jats:sup>7<\/jats:sup>\u2010Leu<jats:sup>8<\/jats:sup>. Furthermore, [<jats:sup>3<\/jats:sup>H]etorphine identified in the bovine adrenal medulla a third high\u2010affinity component, in the presence of 5 \u03bc<jats:italic>M<\/jats:italic> DADLE. This residual interaction was found to be equally stereoselective and presenting K selectivity. Met<jats:sup>5<\/jats:sup>\u2010enkephalyl\u2010Arg<jats:sup>6<\/jats:sup>\u2010Phe<jats:sup>7<\/jats:sup> interacted preferentially with this site. The three K subtypes interacted differentially with monovalent (Na<jats:sup>+<\/jats:sup>, K<jats:sup>+<\/jats:sup>, and Li<jats:sup>+<\/jats:sup>) and divalent (Ca<jats:sup>2+<\/jats:sup>, Mg<jats:sup>2+<\/jats:sup>, and Mn<jats:sup>2+<\/jats:sup>) ions by modification of the apparent concentration of the accessible sites and\/or by changes of the apparent <jats:italic>K<\/jats:italic><jats:sub>D<\/jats:sub> for radioligands. Modifying agents (proteolytic enzymes, thiol\u2010modifying reagents, and A<jats:sub>2<\/jats:sub>\u2010phospholipase) produced different effects on each subtype of the K site, suggesting a different protein (or protein\u2010lipid?) composition.<\/jats:p>","DOI":"10.1111\/j.1471-4159.1985.tb04047.x","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T17:55:06Z","timestamp":1160070906000},"page":"688-699","source":"Crossref","is-referenced-by-count":79,"title":["Interaction of Opiates with Opioid Binding Sites in the Bovine Adrenal Medulla: II. Interaction with K Sites"],"prefix":"10.1111","volume":"45","author":[{"given":"E.","family":"Castanas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bourhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Boudouresque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cantau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,5]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_2_2_1","DOI":"10.1016\/0143-4179(82)90065-8"},{"doi-asserted-by":"publisher","key":"e_1_2_2_3_1","DOI":"10.1007\/978-94-009-6604-8_45"},{"doi-asserted-by":"publisher","key":"e_1_2_2_4_1","DOI":"10.1111\/j.1471-4159.1982.tb08015.x"},{"key":"e_1_2_2_5_1","first-page":"123","article-title":"Quantitative analysis of the binding of ligands to their receptors","volume":"1","author":"Boeynaems J. M.","year":"1975","journal-title":"J. Cyclic Nucleotide Res."},{"doi-asserted-by":"publisher","key":"e_1_2_2_6_1","DOI":"10.1016\/0003-2697(83)90427-X"},{"doi-asserted-by":"publisher","key":"e_1_2_2_7_1","DOI":"10.1016\/0024-3205(83)90501-5"},{"key":"e_1_2_2_8_1","first-page":"38","article-title":"Adrenal medullary opiate receptors: pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma","volume":"25","author":"Castanas E.","year":"1984","journal-title":"Mol. Pharmacol."},{"doi-asserted-by":"publisher","key":"e_1_2_2_9_1","DOI":"10.1111\/j.1471-4159.1985.tb04046.x"},{"doi-asserted-by":"publisher","key":"e_1_2_2_10_1","DOI":"10.1073\/pnas.78.7.4141"},{"doi-asserted-by":"publisher","key":"e_1_2_2_11_1","DOI":"10.1146\/annurev.pa.20.040180.003005"},{"doi-asserted-by":"publisher","key":"e_1_2_2_12_1","DOI":"10.1016\/0006-2952(73)90196-2"},{"doi-asserted-by":"publisher","key":"e_1_2_2_13_1","DOI":"10.1038\/299079a0"},{"key":"e_1_2_2_14_1","first-page":"2946","article-title":"Modulation of nicotinic receptor function by opiate recognition sites highly selective for Met5\u2010enkephalin Arg6\u2010Phe7","volume":"42","author":"Costa E.","year":"1983","journal-title":"Fed. Proc."},{"key":"e_1_2_2_15_1","first-page":"265","volume-title":"Kappa Receptors and Their Ligands","author":"Kosterlitz H. W.","year":"1984"},{"doi-asserted-by":"publisher","key":"e_1_2_2_16_1","DOI":"10.1146\/annurev.pa.20.040180.001221"},{"doi-asserted-by":"publisher","key":"e_1_2_2_17_1","DOI":"10.1016\/0024-3205(82)90381-2"},{"doi-asserted-by":"publisher","key":"e_1_2_2_18_1","DOI":"10.1016\/0003-2697(80)90515-1"},{"doi-asserted-by":"publisher","key":"e_1_2_2_19_1","DOI":"10.1111\/j.1471-4159.1984.tb00921.x"},{"doi-asserted-by":"publisher","key":"e_1_2_2_20_1","DOI":"10.1523\/JNEUROSCI.02-07-00912.1982"},{"doi-asserted-by":"publisher","key":"e_1_2_2_21_1","DOI":"10.1016\/0024-3205(81)90161-2"},{"doi-asserted-by":"publisher","key":"e_1_2_2_22_1","DOI":"10.1111\/j.1471-4159.1982.tb07943.x"},{"key":"e_1_2_2_23_1","first-page":"329","volume-title":"Handbook of Psychopharacology","author":"Snyder S. H.","year":"1975"},{"doi-asserted-by":"publisher","key":"e_1_2_2_24_1","DOI":"10.1016\/0003-2697(80)90385-1"},{"doi-asserted-by":"publisher","key":"e_1_2_2_25_1","DOI":"10.1016\/0024-3205(81)90324-6"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.1985.tb04047.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.1985.tb04047.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:05:51Z","timestamp":1697785551000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.1985.tb04047.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["10.1111\/j.1471-4159.1985.tb04047.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.1985.tb04047.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"type":"print","value":"0022-3042"},{"type":"electronic","value":"1471-4159"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}